- Home
- NVEC vs TERN Comparison
NVEC vs TERN Comparison
Compare NVEC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVEC
- TERN
- Stock Information
- Founded
- NVEC 1989
- TERN 2017
- Country
- NVEC United States
- TERN United States
- Employees
- NVEC N/A
- TERN N/A
- Industry
- NVEC Semiconductors
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- NVEC Technology
- TERN Health Care
- Exchange
- NVEC Nasdaq
- TERN Nasdaq
- Market Cap
- NVEC 359.6M
- TERN 324.0M
- IPO Year
- NVEC 1996
- TERN 2021
- Fundamental
- Price
- NVEC $72.90
- TERN $4.06
- Analyst Decision
- NVEC
- TERN Buy
- Analyst Count
- NVEC 0
- TERN 5
- Target Price
- NVEC N/A
- TERN $15.63
- AVG Volume (30 Days)
- NVEC 89.0K
- TERN 871.0K
- Earning Date
- NVEC 07-16-2025
- TERN 08-04-2025
- Dividend Yield
- NVEC 5.59%
- TERN N/A
- EPS Growth
- NVEC N/A
- TERN N/A
- EPS
- NVEC 3.11
- TERN N/A
- Revenue
- NVEC $25,874,694.00
- TERN N/A
- Revenue This Year
- NVEC N/A
- TERN N/A
- Revenue Next Year
- NVEC N/A
- TERN N/A
- P/E Ratio
- NVEC $23.01
- TERN N/A
- Revenue Growth
- NVEC N/A
- TERN N/A
- 52 Week Low
- NVEC $51.50
- TERN $1.87
- 52 Week High
- NVEC $89.98
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- NVEC 57.54
- TERN 64.02
- Support Level
- NVEC $67.81
- TERN $3.55
- Resistance Level
- NVEC $72.32
- TERN $4.30
- Average True Range (ATR)
- NVEC 2.15
- TERN 0.29
- MACD
- NVEC -0.31
- TERN -0.01
- Stochastic Oscillator
- NVEC 66.19
- TERN 71.13
About NVEC NVE Corporation
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.